This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Cantargia Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Wichtige Informationen
79.2%
Wachstumsrate der Gewinne
51.1%
EPS-Wachstumsrate
| Biotechs Gewinnwachstum | 46.4% |
| Wachstumsrate der Einnahmen | 108.0% |
| Zukünftige Eigenkapitalrendite | 43.3% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | n/a |
Jüngste Aktualisierungen zum künftigen Wachstum
Keine Aktualisierungen
Recent updates
Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2024 | 220 | 158 | 158 | 158 | 1 |
| 12/31/2023 | 271 | -158 | 168 | 168 | 3 |
| 12/31/2022 | N/A | -401 | -403 | -403 | 3 |
| 3/31/2022 | N/A | -411 | -406 | -406 | N/A |
| 12/31/2021 | N/A | -367 | -347 | -346 | N/A |
| 9/30/2021 | N/A | -319 | -302 | -301 | N/A |
| 6/30/2021 | N/A | -255 | -231 | -230 | N/A |
| 3/31/2021 | N/A | -206 | -187 | -186 | N/A |
| 12/31/2020 | N/A | -173 | -165 | -156 | N/A |
| 9/30/2020 | N/A | -153 | -165 | -149 | N/A |
| 6/30/2020 | N/A | -139 | -151 | -135 | N/A |
| 3/31/2020 | N/A | -127 | -144 | -129 | N/A |
| 12/31/2019 | N/A | -111 | -118 | -111 | N/A |
| 9/30/2019 | N/A | -102 | -97 | -97 | N/A |
| 6/30/2019 | N/A | -98 | -92 | -92 | N/A |
| 3/31/2019 | N/A | -101 | -88 | -88 | N/A |
| 12/31/2018 | N/A | -91 | -105 | -105 | N/A |
| 9/30/2018 | N/A | -78 | -72 | -72 | N/A |
| 6/30/2018 | N/A | -68 | -65 | -65 | N/A |
| 3/31/2018 | N/A | -56 | -54 | -54 | N/A |
| 12/31/2017 | N/A | -60 | -41 | -41 | N/A |
| 9/30/2017 | N/A | -65 | -69 | -69 | N/A |
| 6/30/2017 | N/A | -66 | -64 | -64 | N/A |
| 3/31/2017 | N/A | -58 | -54 | -54 | N/A |
| 12/31/2016 | N/A | -47 | -42 | -42 | N/A |
| 9/30/2016 | N/A | -34 | -28 | -26 | N/A |
| 6/30/2016 | N/A | -24 | -23 | -21 | N/A |
| 3/31/2016 | N/A | -22 | -20 | -19 | N/A |
| 12/31/2015 | N/A | -17 | N/A | -30 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CANTA BTA is forecast to remain unprofitable over the next 3 years.
Ertrag vs. Markt: CANTA BTA is forecast to remain unprofitable over the next 3 years.
Hohe Wachstumserträge: CANTA BTA is forecast to remain unprofitable over the next 3 years.
Einnahmen vs. Markt: CANTA BTA's revenue (108% per year) is forecast to grow faster than the Swedish market (9.3% per year).
Hohe Wachstumseinnahmen: CANTA BTA's revenue (108% per year) is forecast to grow faster than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CANTA BTA's Return on Equity is forecast to be very high in 3 years time (43.3%).